本文へ移動
cccskills
無料GitHub で公開

es-pump-hybrid-continuation

This skill determines whether a patient using a hybrid closed-loop insulin pump can continue this therapy upon hospital admission. It is triggered by questions such as "Can hybrid closed-loop pump be continued given hospital constraints?"

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.9 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Assess feasibility of continuing hybrid closed-loop insulin pump at admission

STEP 1 — Gather Information

Collect data on pump type (hybrid closed-loop), baseline settings, CGM status, anticipated hospital LOS, contraindications (impaired consciousness, inability to adjust pump, critical illness, DKA, HHS), hospital resources (expertise in insulin pump therapy, policies, supplies), and potential interference (MRI/CT, vasoactive meds, skin infection/hypoperfusion, acetaminophen >4 g/day, dopamine, vitamin C, hydroxyurea). Flag any absolute contraindications to pump use.

STEP 2 — Rule In / Rule Out

Determine if continuation is feasible: (hospital has expertise in insulin pump therapy) OR (anticipated LOS ≤1‑2 days). If YES, proceed to assess pump/CGM function; if NO, transition to scheduled subcutaneous basal bolus insulin (BBI) therapy.

STEP 3 — Classify or Stratify

Assess whether CGM and pump can function without hospital interference. If YES, continue hybrid closed-loop with CGM guidance. If NO (interference expected or CGM likely to fail), evaluate if pump can be used in manual mode (patient able to adjust settings, supplies available, no contraindications). If manual mode feasible, plan for manual pump use; if not, transition to SC BBI.

STEP 4 — Decide

If CGM/pump functional without interference: continue hybrid closed-loop therapy with CGM-guided adjustments. If CGM/pump not functional but manual mode feasible: continue insulin pump in manual mode with patient self-management and POC‑BG confirmation. If neither feasible: transition to scheduled subcutaneous basal bolus insulin (BBI) therapy.

Clinical Guardrails / Mimics / Pitfalls

Do not continue pump if patient has impaired consciousness, inability to adjust pump settings, critical illness (ICU), DKA, HHS, or if hospital lacks expertise and anticipated LOS >1‑2 days without a transition plan. Avoid interference from MRI/CT, vasoactive pressors, acetaminophen >4 g/day, dopamine, vitamin C, hydroxyurea. Do not assume pump will work without verifying supplies, patient consent, and ability to self‑manage.

Concrete Clinical Example

A 58‑year‑old patient with type 1 diabetes using a hybrid closed‑loop pump is admitted for elective surgery. Hospital has pump expertise, anticipated LOS 2 days, no contraindications, no expected interference. Continue hybrid closed‑loop pump with CGM guidance.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する